Binimetinib and Encorafenib
About
Membership operator: AND
Therapies: 2
Therapies
Binimetinib (tx:ncit:C84865)
Encorafenib (tx:ncit:C98283)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (4) HC (2) | BRAF p.V600E | Melanoma | Binimetinib, Encorafenib | |
| FDA (4) HC (1) | BRAF p.V600K | Melanoma | Binimetinib, Encorafenib | |
| FDA (4) | BRAF p.V600E | Non-Small Cell Lung Cancer | Binimetinib, Encorafenib |